Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responsess against oxidized low density lipoprotein

Details for Australian Patent Application No. 2002246484 (hide)

International Classifications

Event Publications

10 April 2003 Application Open to Public Inspection

Published as AU-B-2002246484

19 April 2007 Application Accepted

Published as AU-B-2002246484

14 June 2007 Corrigenda

Applications Accepted - Name Index Under the names Forskarpatent I Syd AB and Cedars-Sinai Medical Center, Application No. 2002246484, under INID (54), correct the invention title to read Peptide-based immunization therapy for treatment of atherosclerosis and development of Corrigenda peptide-based assay for determination of immune responses against oxidized low density lipoprotein

21 June 2007 Corrigenda

Applications Accepted - Name Index Under the names Forskarpatent I Syd AB and Cedars-Sinai Medical Center, Application No. 2002246484, under INID (54), correct the invention title to read Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein

16 August 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.